• 1627 Citations
19952019
If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests:

Limb development.
Thalidomide
Clubfoot
Vascular development

Qualifications:

B.Sc. (Hons)
Ph.D
CASLAT

Fingerprint Dive into the research topics where Neil Vargesson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Thalidomide Medicine & Life Sciences
Extremities Medicine & Life Sciences
Embryonic Structures Medicine & Life Sciences
Zebrafish Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Teratogenesis Medicine & Life Sciences
Chickens Medicine & Life Sciences
Embryonic Development Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1995 2019

Open Access
Developmental Biology
Embryonic Development
Regeneration
Extremities
1 Citation (Scopus)
8 Downloads (Pure)

The teratogenic effects of thalidomide on limbs

Vargesson, N., 1 Jan 2019, In : Journal of hand surgery-European volume. 44, 1, p. 88-95 8 p.

Research output: Contribution to journalArticle

Open Access
File
Thalidomide
Extremities
Morning Sickness
Ectromelia
Erythema Nodosum

Vascular anomalies of the upper limb

Mende, K., Vargesson, N. & Sivakumar, B., 1 Mar 2019, In : Journal of hand surgery-European volume. 44, 3, p. 233-241 9 p.

Research output: Contribution to journalArticle

Upper Extremity
Blood Vessels
Terminology
Hand
Pathology

Vgll3 interacts with Yap/Taz-Tead1-4-dependent gene expression in skeletal muscle

Figeac, N., Mohamed, A. A. D., Sun, C., Schonfelder, M., Gomez, D., Garcia-Munoz, A., Missiaglia, E., Collie-Duguid, E., De Mello, V., Pobbati, A. V., Jaka, O., Harridge, S. D. R., Hong, W., Shipley, J., Vargesson, N., Zammit, P. S. & Wackerhage, H., Mar 2019, In : European Journal of Translational Myology. 29, 1, p. 53-53 1 p.

Research output: Contribution to journalAbstract

Open Access
File
1 Downloads (Pure)

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle

Figeac, N., Mohamed, A. D., Sun, C., Schönfelder, M., Matallanas, D., Garcia-Munoz, A., Missiaglia, E., Collie-Duguid, E., De Mello, V., Pobbati, A. V., Pruller, J., Jaka, O., Harridge, S. D. R., Hong, W., Shipley, J., Vargesson, N., Zammit, P. S. & Wackerhage, H., 5 Jul 2019, In : Journal of Cell Science. 132, jcs225946 .

Research output: Contribution to journalArticle

Open Access
File
Muscle Development
Skeletal Muscle
Muscles
Myoblasts
Alveolar Rhabdomyosarcoma

Prizes

Principal's Prize in Public Engagement with Research - Senior Category (Winner) 2017

Neil Vargesson (Recipient), 28 Aug 2017

Prize: Prize (including medals and awards)

File
WHO
speaking
news
Group

Press / Media

Why I can’t agree with the conclusions of the report on Primodos

Neil Vargesson

6/12/17

1 Media contribution

Press/Media: Articles in 'The Conversation'

Is Primodos ‘the forgotten thalidomide’?

Neil Vargesson

8/02/16

1 item of Media coverage

Press/Media: Articles in 'The Conversation'

Thalidomide: the drug with a dark side but an enigmatic future

Neil Vargesson

14/12/15

2 items of Media coverage

Press/Media: Research

Thalidomide: the drug with a dark side but an enigmatic future

Neil Vargesson

10/12/15

1 item of Media coverage

Press/Media: Articles in 'The Conversation'